https://www.selleckchem.com/pr....oducts/tqb-3804-egrf
Rituximab has been widely used in many autoimmune diseases. To evaluate the infection risk of rituximab in autoimmune hematological disorders. Retrospectively studied and compared the clinical data of 89 patients in our hospital who used low-dose rituximab (group R) or pulse cyclophosphamide (group C) for their refractory/relapsed autoimmune hematological diseases from January 2011 to January 2017. The kinds of their diseases included autoimmune hemolytic disease (AIHA), Evans syndrome, and idiopathic thrombocytopenic purpura
Like
Comment
Share
